|
1
|
Uchiyama T: Human T cell leukemia virus
type I (HTLV-I) and human diseases. Annu Rev Immunol. 15:15–37.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yoshida M: Multiple viral strategies of
HTLV-1 for dysregulation of cell growth control. Annu Rev Immunol.
19:475–496. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Linker C, Damon L, Ries C and Navarro W:
Intensified and shortened cyclical chemotherapy for adult acute
lymphoblastic leukemia. J Clin Oncol. 20:2464–2471. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hijiya N, Thomson B, Isakoff MS, Silverman
LB, Steinherz PG, Borowitz MJ, Kadota R, Cooper T, Shen V, Dahl G,
et al: Phase 2 trial of clofarabine in combination with etoposide
and cyclophosphamide in pediatric patients with refractory or
relapsed acute lymphoblastic leukemia. Blood. 118:6043–6049. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chabner BA and Roberts TG Jr: Timeline:
Chemotherapy and the war on cancer. Nat Rev Cancer. 5:65–72. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Helleday T, Petermann E, Lundin C, Hodgson
B and Sharma RA: DNA repair pathways as targets for cancer therapy.
Nat Rev Cancer. 8:193–204. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
O'Grady S, Finn SP, Cuffe S, Richard DJ,
O'Byrne KJ and Barr MP: The role of DNA repair pathways in
cisplatin resistant lung cancer. Cancer Treat Rev. 40:1161–1170.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rich T, Allen RL and Wyllie AH: Defying
death after DNA damage. Nature. 407:777–783. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Khanna KK and Jackson SP: DNA
double-strand breaks: Signaling, repair and the cancer connection.
Nat Genet. 27:247–254. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lombard DB, Chua KF, Mostoslavsky R,
Franco S, Gostissa M and Alt FW: DNA repair, genome stability, and
aging. Cell. 120:497–512. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Brooks CL and Gu W: How does SIRT1 affect
metabolism, senescence and cancer? Nat Rev Cancer. 9:123–128. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bordone L and Guarente L: Calorie
restriction, SIRT1 and metabolism: Understanding longevity. Nat Rev
Mol Cell Biol. 6:298–305. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jeong J, Juhn K, Lee H, Kim SH, Min BH,
Lee KM, Cho MH, Park GH and Lee KH: SIRT1 promotes DNA repair
activity and deacetylation of Ku70. Exp Mol Med. 39:8–13. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Furukawa-Hibi Y, Kobayashi Y, Chen C and
Motoyama N: FOXO transcription factors in cell-cycle regulation and
the response to oxidative stress. Antioxid Redox Signal. 7:752–760.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Brunet A, Sweeney LB, Sturgill JF, Chua
KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, et
al: Stress-dependent regulation of FOXO transcription factors by
the SIRT1 deacetylase. Science. 303:2011–2015. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yuan Z, Zhang X, Sengupta N, Lane WS and
Seto E: SIRT1 regulates the function of the Nijmegen breakage
syndrome protein. Mol Cell. 27:149–162. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li K, Casta A, Wang R, Lozada E, Fan W,
Kane S, Ge Q, Gu W, Orren D and Luo J: Regulation of WRN protein
cellular localization and enzymatic activities by SIRT1-mediated
deacetylation. J Biol Chem. 283:7590–7598. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ming M, Shea CR, Guo X, Li X, Soltani K,
Han W and He YY: Regulation of global genome nucleotide excision
repair by SIRT1 through xeroderma pigmentosum C. Proc Natl Acad Sci
USA. 107:22623–22628. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yeung F, Hoberg JE, Ramsey CS, Keller MD,
Jones DR, Frye RA and Mayo MW: Modulation of NF-kappaB-dependent
transcription and cell survival by the SIRT1 deacetylase. EMBO J.
23:2369–2380. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yuan H, Wang Z, Li L, Zhang H, Modi H,
Horne D, Bhatia R and Chen W: Activation of stress response gene
SIRT1 by BCR-ABL promotes leukemogenesis. Blood. 119:1904–1914.
2012. View Article : Google Scholar :
|
|
21
|
Lopez-Royuela N, Rathore MG, Allende-Vega
N, Annicotte JS, Fajas L, Ramachandran B, Gulick T and Villalba M:
Extracellular-signal-regulated kinase 5 modulates the antioxidant
response by transcriptionally controlling Sirtuin 1 expression in
leukemic cells. Int J Biochem Cell Biol. 53:253–261. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sasca D, Hähnel PS, Szybinski J, Khawaja
K, Kriege O, Pante SV, Bullinger L, Strand S, Strand D, Theobald M,
et al: SIRT1 prevents genotoxic stress-induced p53 activation in
acute myeloid leukemia. Blood. 124:121–133. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kozako T, Aikawa A, Shoji T, Fujimoto T,
Yoshimitsu M, Shirasawa S, Tanaka H, Honda S, Shimeno H, Arima N,
et al: High expression of the longevity gene product SIRT1 and
apoptosis induction by sirtinol in adult T-cell leukemia cells.
International journal of cancer. Int J Cancer. 131:2044–2055. 2012.
View Article : Google Scholar
|
|
24
|
Luo J, Nikolaev AY, Imai S, Chen D, Su F,
Shiloh A, Guarente L and Gu W: Negative control of p53 by Sir2alpha
promotes cell survival under stress. Cell. 107:137–148. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vaziri H, Dessain SK, Ng Eaton E, Imai SI,
Frye RA, Pandita TK, Guarente L and Weinberg RA: hSIR2(SIRT1)
functions as an NAD-dependent p53 deacetylase. Cell. 107:149–159.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Saunders LR and Verdin E: Sirtuins:
Critical regulators at the crossroads between cancer and aging.
Oncogene. 26:5489–5504. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu T, Liu PY and Marshall GM: The
critical role of the class III histone deacetylase SIRT1 in cancer.
Cancer Res. 69:1702–1705. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nitiss JL: Targeting DNA topoisomerase II
in cancer chemotherapy. Nat Rev Cancer. 9:338–350. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu CC, Li TK, Farh L, Lin LY, Lin TS, Yu
YJ, Yen TJ, Chiang CW and Chan NL: Structural basis of type II
topoisomerase inhibition by the anticancer drug etoposide. Science.
333:459–462. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li Z, Sun B, Clewell RA, Adeleye Y,
Andersen ME and Zhang Q: Dose-response modeling of
etoposide-induced DNA damage response. Toxicol Sci. 137:371–384.
2014. View Article : Google Scholar
|
|
31
|
Rogakou EP, Pilch DR, Orr AH, Ivanova VS
and Bonner WM: DNA double-stranded breaks induce histone H2AX
phosphorylation on serine 139. J Biol Chem. 273:5858–5868. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lieber MR: NHEJ and its backup pathways in
chromosomal translocations. Nat Struct Mol Biol. 17:393–395. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sargent RG, Brenneman MA and Wilson JH:
Repair of site-specific double-strand breaks in a mammalian
chromosome by homologous and illegitimate recombination. Mol Cell
Biol. 17:267–277. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Arnaudeau C, Lundin C and Helleday T: DNA
double-strand breaks associated with replication forks are
predominantly repaired by homologous recombination involving an
exchange mechanism in mammalian cells. J Mol Biol. 307:1235–1245.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Moynahan ME and Jasin M: Mitotic
homologous recombination maintains genomic stability and suppresses
tumorigenesis. Nat Rev Mol Cell Biol. 11:196–207. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Oberdoerffer P, Michan S, McVay M,
Mostoslavsky R, Vann J, Park SK, Hartlerode A, Stegmuller J, Hafner
A, Loerch P, et al: SIRT1 redistribution on chromatin promotes
genomic stability but alters gene expression during aging. Cell.
135:907–918. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang Z, Yuan H, Roth M, Stark JM, Bhatia R
and Chen WY: SIRT1 deacetylase promotes acquisition of genetic
mutations for drug resistance in CML cells. Oncogene. 32:589–598.
2013. View Article : Google Scholar
|
|
38
|
Arden KC: Multiple roles of FOXO
transcription factors in mammalian cells point to multiple roles in
cancer. Exp Gerontol. 41:709–717. 2006. View Article : Google Scholar : PubMed/NCBI
|
